PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Pharmaceutical industry – Market size and forecast 2017-2022 • Biotechnology sector – Market size and forecast 2017-2022 • Others – Market size and forecast 2017-2022 • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Outsourcing of drug discovery process • Increasing demand for portable instruments • Global initiatives encouraging proteomics research PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bruker • Charles River • PerkinElmer • Rigaku • Shimadzu • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global X-ray crystallography market – Market size and forecast 2017-2022 ($ mn) Exhibit 08: Global X-ray crystallography market – Year-over-year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017 Exhibit 17: Customer landscape Exhibit 18: Global X-ray crystallography market by end-user – Market share 2017-2022 (%) Exhibit 19: Comparison by end-user Exhibit 20: Global X-ray crystallography market by pharmaceutical industry – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Global X-ray crystallography market by pharmaceutical industry – Year-over-year growth 2018-2022 (%) Exhibit 22: Global X-ray crystallography market by biotechnology sector – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Global X-ray crystallography market by biotechnology sector – Year-over-year growth 2018-2022 (%) Exhibit 24: Global X-ray crystallography market by others – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Global X-ray crystallography market by others – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by end-user Exhibit 27: Global X-ray crystallography market by region – Market share 2017-2022 (%) Exhibit 28: Regional comparison Exhibit 29: X-ray crystallography market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 30: X-ray crystallography market in Americas – Year-over-year growth 2018-2022 (%) Exhibit 31: Top three countries in Americas Exhibit 32: X-ray crystallography market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 33: X-ray crystallography market in EMEA – Year-over-year growth 2018-2022 (%) Exhibit 34: Top three countries in EMEA Exhibit 35: X-ray crystallography market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 36: X-ray crystallography market in APAC – Year-over-year growth 2018-2022 (%) Exhibit 37: Top three countries in APAC Exhibit 38: Market opportunity Exhibit 39: Average percentage of GDP spent by OECD countries on R&D Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Bruker overview Exhibit 46: Bruker – Business segments Exhibit 47: Bruker – Organizational developments Exhibit 48: Bruker – Geographic focus Exhibit 49: Bruker – Segment focus Exhibit 50: Bruker – Key offerings Exhibit 51: Charles River overview Exhibit 52: Charles River – Business segments Exhibit 53: Charles River – Organizational developments Exhibit 54: Charles River – Geographic focus Exhibit 55: Charles River – Segment focus Exhibit 56: Charles River – Key offerings Exhibit 57: PerkinElmer overview Exhibit 58: PerkinElmer – Business segments Exhibit 59: PerkinElmer – Organizational developments Exhibit 60: PerkinElmer – Geographic focus Exhibit 61: PerkinElmer – Segment focus Exhibit 62: PerkinElmer – Key offerings Exhibit 63: Rigaku overview Exhibit 64: Rigaku – Business segments Exhibit 65: Rigaku – Organizational developments Exhibit 66: Rigaku – Key offerings Exhibit 67: Shimadzu overview Exhibit 68: Shimadzu – Business segments Exhibit 69: Shimadzu – Organizational developments Exhibit 70: Shimadzu – Geographic focus Exhibit 71: Shimadzu – Segment focus Exhibit 72: Shimadzu – Key offerings Exhibit 73: Thermo Fisher Scientific overview Exhibit 74: Thermo Fisher Scientific – Business segments Exhibit 75: Thermo Fisher Scientific – Organizational developments Exhibit 76: Thermo Fisher Scientific – Geographic focus Exhibit 77: Thermo Fisher Scientific – Segment focus Exhibit 78: Thermo Fisher Scientific – Key offerings

Bruker Charles River PerkinElmer Rigaku Shimadzu Thermo Fisher Scientific